Page last updated: 2024-08-23

lonidamine and curcumin

lonidamine has been researched along with curcumin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aller, P; Calviño, E; de Blas, E; Sánchez, Y; Simón, GP1
Steinman, TI1
Dhar, S; Marrache, S1

Reviews

1 review(s) available for lonidamine and curcumin

ArticleYear
Polycystic kidney disease: a 2011 update.
    Current opinion in nephrology and hypertension, 2012, Volume: 21, Issue:2

    Topics: Antineoplastic Agents; Benzazepines; Curcumin; Everolimus; Gastrointestinal Agents; Glomerular Filtration Rate; Humans; Hypertension; Hypoglycemic Agents; Immunosuppressive Agents; Indazoles; Kidney; Metformin; Octreotide; Organ Size; Polycystic Kidney, Autosomal Dominant; Sirolimus; Sodium; Tolvaptan

2012

Other Studies

2 other study(ies) available for lonidamine and curcumin

ArticleYear
Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines.
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 335, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Arsenic Trioxide; Arsenicals; Blotting, Western; Cell Survival; Curcumin; Electrophoretic Mobility Shift Assay; Flow Cytometry; Glutathione; HL-60 Cells; Humans; Indazoles; Membrane Potentials; Mitochondria; Oxidants; Oxides; Protein Kinase Inhibitors; Protein Kinases; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; U937 Cells

2010
Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics.
    Proceedings of the National Academy of Sciences of the United States of America, 2012, Oct-02, Volume: 109, Issue:40

    Topics: 2,4-Dinitrophenol; Adipogenesis; alpha-Tocopherol; Analysis of Variance; Bioengineering; Curcumin; Drug Delivery Systems; Humans; Indazoles; Mitochondrial Diseases; Nanoparticles; Polyethylene Glycols; Polyglactin 910; Polymers

2012